68Ga-DOTA-SFITGv6

N/A

Report date: 2025/11/18 17:45:26

NME

Base Information

Drug Name68Ga-DOTA-SFITGv6

Drug Alias Name68Ga-DOTA-SFITGv6

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) +[4]

Mechanisms of ActionIntegrin alpha-V/beta-6 binders

TargetsIntegrin alpha-V/beta-6

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of Head and Neck

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGerman Cancer Research Center (Dkfz)Heidelberg University Hospital

China Registration ClassN/A

Develop Information

Active CompaniesGerman Cancer Research Center (Dkfz)Heidelberg University Hospital

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of Head and Neck

Inactive IndicationsN/A

Other Information

ATC CodeN/A